title: Nutritional management of plasma lipid disorders.
abstract: Prevention of vascular disease and acute pancreatitis is the goal of hyperlipidemia treatment. The risk of coronary heart disease (CHD) increases with increasing plasma cholesterol levels because low-density lipoprotein (LDL), the major carrier of cholesterol in the plasma, is atherogenic. High-density lipoprotein (HDL), especially the HDL2 subfraction, protects against CHD. Hypertriglyceridemia, although not an independent risk factor for CHD, is generally accompanied by low HDL cholesterol (HDLch), which may predispose to CHD. Reducing plasma LDL and raising HDL levels are thus goals in preventing CHD. Serum LDL levels may be lowered by reducing saturated fat and cholesterol intake; weight loss may decrease LDL but is more effective in lowering plasma triglycerides and raising HDLch. The percent of total calories from polyunsaturated, monounsaturated, and saturated fats should be less than 10%, up to 10-15%, and less than 10%, respectively. High cholesterol intake increases the flux of cholesterol, which may be harmful to arterial walls, but beyond a certain point does not increase plasma cholesterol levels. Some diets change the composition rather than the level of LDL and apoproteins. Weight reduction and maintenance are the most effective dietary measures to lower plasma triglycerides; omega-3 fatty acids (fish oils) have shown promise in reducing triglyceride but not cholesterol levels. Substitution of starch for sugar lowered triglyceride levels toward normal in hypertriglyceridemia patients. Fasting triglyceride levels rise in all individuals fed high-carbohydrate diets, but the high levels persist in hypertriglyceridemia patients. Weight loss, cessation of cigarette smoking, increased physical activity, good control of diabetes, and moderate alcohol use all raise HDLch levels. Vitamin E deficiency causes neurological sequelae in children with severe malabsorption problems due to abetalipoproteinemia or cholestatic liver disease.
authors.affiliation: Johns Hopkins School of Medicine, Baltimore, Maryland 21205.
authors.forename: S
authors.initials: S
authors.lastname: Margolis
authors.forename: A S
authors.initials: AS
authors.lastname: Dobs
mesh_terms: D000208:Acute Disease; D002791:Cholesterol, Dietary; D008076:Cholesterol, HDL; D003327:Coronary Disease / Q000178:diet therapy; D004040:Dietary Carbohydrates / Q000627:therapeutic use; D004043:Dietary Fiber / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000178:diet therapy*; D010195:Pancreatitis / Q000517:prevention & control; D012106:Research; D015431:Weight Loss
chemical_list: D002791:Cholesterol, Dietary; D008076:Cholesterol, HDL; D004040:Dietary Carbohydrates; D004043:Dietary Fiber